Healthcare -
Biotechnology - NASDAQ - US
$ 9.33
2.08 %
$ 465 M
Market Cap
-2.55
P/E
Price Target
Average
221.54%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
22.28%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Mineralys Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for MLYS of $30 , with forecasts ranging from
a
low of
$30 to a high of $30 .
MLYS Lowest Price Target
Wall Street Target
30 USD
221.54%
MLYS Average Price Target
Wall Street Target
30 USD
221.54%
MLYS Highest Price Target
Wall Street Target
30 USD
221.54%
REVENUE FORECAST
Revenue Forecast Chart MLYS
EBIT FORECAST
EBIT Forecast Chart MLYS
NET INCOME FORECAST
Net Income Chart MLYS